Carboxamide Derivatives and Use Thereof
US-2016031873-A1 · Feb 4, 2016 · US
Analgesic compounds
US10653681B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10653681-B2 |
| Application number | US-201716085505-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 15, 2017 |
| Priority date | Mar 16, 2016 |
| Publication date | May 19, 2020 |
| Grant date | May 19, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed herein are compounds of Formula (I), methods of synthesizing compounds of Formula (I), and methods of using compounds of Formula (I) as an analgesic.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for reducing or at least partially preventing pain or fever comprising administering an effective amount of a medicament comprising any of the compound selected from the group consisting of: or a pharmaceutically acceptable salt of any of the foregoing. 2. The method of claim 1 , further comprising administering an opioid analgesic in combination. 3. The method of claim 2 , wherein the opioid analgesic is selected from the group consisting of morphine, codeine, hydrocodone, oxycodone, fentanyl, pethidine, methadone, pentazocine, sufentanil, levorphanol, dihydrocodeine, nalbuphine, butorphanol, tramadol, meptazinol, buprenorphine, dipipanone, alfentanil, remifentanil, oxymorphone, tapentadol, propoxyphene and hydromorphone. 4. The method of claim 1 , wherein the compound is administered intravenously, administered orally or administered intraperitoneally. 5. The method of claim 1 , wherein the pain is acute pain. 6. The method of claim 1 , wherein the pain is post-operative pain. 7. The method of claim 1 , wherein the pain is chronic pain. 8. The method of claim 1 , wherein the pain is nociceptive pain. 9. The method of claim 1 , wherein the pain is selected from the group consisting of osteoarthritis pain, rheumatoid arthritis pain, migraine pain, lower back pain, cancer pain and fibromyalgia pain. 10. The method of claim 1 , wherein the pain is neuropathic pain. 11. The method of claim 1 , wherein the pain is visceral pain. 12. The method of claim 1 , wherein the pain is mixed pain.
Assignees
Inventors
Classifications
with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom · CPC title
Oxadiazoles · CPC title
Unsubstituted amino or imino radicals · CPC title
1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles · CPC title
Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine {or methadone} · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10653681B2 cover?
- Disclosed herein are compounds of Formula (I), methods of synthesizing compounds of Formula (I), and methods of using compounds of Formula (I) as an analgesic.
- Who is the assignee on this patent?
- Recurium Ip Holdings Llc
- What technology area does this patent fall under?
- Primary CPC classification A61K31/433. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).